Latest Earnings Results: Q2 '26
Estimated EPS
-$0.90
Reported EPS
-$0.71
Surprise
+21.27%
Estimated Rev
$26.03M
Reported Rev
$26.86M
Surprise
+3.21%
• Reported GAAP EPS of -$0.71 up 55.62% YoY • Reported revenue of $26.86M up 34.18% YoY • Biodesix expects total revenue of $108-114 million for full year 2026, with the midpoint representing approximately 25% growth over 2025, and maintains gross margin guidance of approximately 80% for 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.75 | -- | -- | N/A |
Q2 '26 | -$0.90 | -$0.71 | 21.27% | BEAT |
Q1 '26 | -$1.13 | -$0.81 | 28.31% | BEAT |
Q4 '25 | -$0.86 | -$0.49 | 43.04% | BEAT |
Q3 '25 | -$1.49 | -$1.16 | 22.15% | BEAT |